ftInvstr
STAR · Healthcare ₹1058.3 +0.5% Mkt Cap ₹9790 Cr overvalued

STAR

Healthcare Drug Manufacturers - Specialty & Generic
₹1058.3
+0.5% today · 30d +5.94%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for STAR. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹1265 Cr
+13.01% YoY
NET PROFIT
₹165 Cr
+56.73% YoY
OPM
18.47%
-1.61pp YoY
EPS
₹17.02
PE 17.72
Intrinsic value · DCF ₹213.26 · Margin of safety -79.8% (overvalued) · FCF yield 2.86%
◇ Sector Position
PEERPEROCE %
STAR17.7219.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
63
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation CHEAP 75
Growth MUTED 42
Profitability HIGH 78
Technicals NEUTRAL 65
Risk ELEVATED 30
Key Stats
TTM PE
17.72
P/B
3.5
52W HIGH
₹1231.0
OFF HIGH
-14.03%
DIV YIELD
0.47%
MKT CAP
₹9790 Cr
◉ Active Signals
MACDBullish11.5166
RSI(14)Bullish61.12
Street Consensus
3 analysts
₹1338.67
mean target
Low ₹1254.0Now ₹1058.3High ₹1410.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold STAR and at what entry.

Sign up freeSign in